Start Pill
Table of Contents
show
About Sonoma BioTherapeutics
Sonoma BioTherapeutics seattle-based company leading the development of adoptive Treg therapies cell for autoimmune.
Website: Learn more on Sonoma BioTherapeutics’s website
Crunchbase: Follow on Crunchbase
[adace-ad id=”4426″]Series A – Sonoma BioTherapeutics
| Amount Raised | 30000000 USD |
| Announced Date | 2020-09-30 |
| Equity Only Funding | Yes |
| Organization Location | South San Francisco, California, United States, North America |
| Funding Status | Early Stage Venture |
| Number of Funding Rounds | 2 |
| Lead Investors | |
| Number of Investors | 8 |
| Number of Partner Investors | 2 |
